Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00798551 · ClinicalTrials.gov registry record · NA

Emergency Department Interventions to Improve Blood Pressure Follow-up

A NA study, sponsored by University of Nebraska.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT00798551: Completed NA study, sponsored by University of Nebraska.

NCT00798551 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00798551, a NA study, has completed, sponsored by University of Nebraska.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

Hypertension affects approximately 65 million people in the United States and approximately 20 million individuals remain undiagnosed. In Emergency Room visits, many as one third of the patients were noted to have elevated BP readings, two thirds of which could benefit from further therapy or closer clinic follow-up. However primary care follow-up after discharge with an elevated BP is surprisingly low. The purpose of this study is to measure the follow-up rate after the Emergency Room visit in individuals identified with elevated blood pressure after a brief counseling regarding risks of elevated blood pressure.

Primary Outcome

The purpose of this study is to measure the follow-up rate after the ED visit in individuals identified with elevated blood pressure after a brief counseling regarding risks of elevated blood pressure.

Interventions

  • BEHAVIORAL Risk counseling

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2008-04-16
Est. Completion 2010-12-20
Phase NA
University of Nebraska

407 total trials

What the finished NCT00798551 record still lists

NCT00798551 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Risk counseling is the first listed.

NCT00798551 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00798551 about?

NCT00798551 is a clinical study titled "Emergency Department Interventions to Improve Blood Pressure Follow-up". Hypertension affects approximately 65 million people in the United States and approximately 20 million individuals remain undiagnosed. In Emergency Room visits, many as one third of the patients were noted to have elevated BP readings, two thirds of which could benefit from further therapy or closer...

What is the current status of trial NCT00798551?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2008-04-16. Estimated completion is 2010-12-20.

What interventions are being tested in trial NCT00798551?

The interventions under investigation include: Risk counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT00798551?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00798551's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00798551, the US trial registry maintained by the National Library of Medicine. NCT00798551 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.